Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022

Michael Leithead Maintained (CC) at Hold with Decreased Target to $30 on, Sep 27th, 2022

Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $46 to $30 on, Sep 27th, 2022.

Michael has made no other calls on CC in the last 4 months.



There are 4 other peers that have a rating on CC. Out of the 4 peers that are also analyzing CC, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joshua Spector of "UBS" Maintained at Hold with Increased Target to $37 on, Friday, July 29th, 2022
  • Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $44 on, Tuesday, June 14th, 2022


These are the ratings of the 2 analyists that currently disagree with Michael


  • John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $46 on, Friday, September 23rd, 2022
  • Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Thursday, September 22nd, 2022